# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distrib...
NAYA Biosciences, Inc. ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough trea...
Maxim Group analyst Jason McCarthy upgrades NAYA Biosciences (NASDAQ:NAYA) from Hold to Buy and announces $2 price target.